feed,title,long_url,short_url
Benzinga,"Bristol Myers' Psoriasis Med Deucravacitinib Superior To Amgen's Otezla, New Data Shows",https://benzinga.com/general/biotech/21/04/20772489/bristol-myers-psoriasis-med-deucravacitinib-superior-to-amgens-otezla-new-data-shows,https://j.mp/3aAfhmj
